Polypharmacy is an Indicator of Bad Practice and Low Quality in General Medicine

Journal Title: Journal of Quality in Health Care & Economics (JQHE) - Year 2019, Vol 2, Issue 4

Abstract

Quality indicators are increasingly used as a tool to achieve safe and quality clinical care. A significant number of them focus on drug therapy, but few address the problem of polypharmacy in general medicine. All patients, especially elderly patients, those with certain pathologies, those with multimorbidity, or those who live in institutions, are exposed to polypharmacy. The prescription of contraindicated or potentially inappropriate medications is also common. Although polypharmacy is sometimes unavoidable, this indicator has been associated with increased morbidity and mortality. The prevalence of polypharmacy is high, and could reach 20%. But, the main thing is that there is a great variability among general practitioners (GPs), which can vary from 4-5% until 18-30% according to GP, in the same geographical area and with lists of random and similar patients. Thus, the main cause of polypharmacy (of excessive use of drugs) is the professional; the prevalence of polypharmacy does not justify itself exclusively by the presence of the multimorbidity or of elderly people, neither is randomly distributed. Polypharmacy does not depend on the size GP' patients list (large lists may have little polypharmacy and small lists a lot of polypharmacy). It can be hypothesized that the presence of polypharmacy is an indicator of malpractice and poor quality of the general medical service, which should be used to improve the clinical care of patients. Therefore, it is imperative to monitor and optimize the use of medications in general medicine. This creates an opportunity to minimize adverse outcomes related to the use of medications and to improve the quality of care, possible cost savings and improve clinical outcomes. Additional research should deepen this proposal that high frequency of polypharmacy between different practices in general medicine is an indicator of poor quality of care in those GPs.

Authors and Affiliations

Turabian JL*

Keywords

Related Articles

Tetravalent Flu Vaccine in Italy: A Budget Impact Analysis (BIA)

Introduction: Influenza is an important problem of Public Health and source of costs: it’s the main cause of school and work absences, GP (general practitioner) consultation, hospitalization for the possible implication...

Patient Safety and Unplanned Extubation in a Pediatric Intensive Care Unit: A Analytical Observational Study

Introduction: Unplanned extubation (UE) is characterized by the removal or displacement of the endotracheal tube (ETT). Objectives: To analyze the incidence of unplanned extubation, characterize the most prevalent cases...

The Detrimental Effects of Surgical Smoke: Promoting Safety in an Operating Room Team-A Mixed Methods Approach

Background: Electrosurgical or electrocautery technology is one of the most widely used in the world, yet no federal agency has mandated the use of electrosurgical filter devices for the protection of surgical teams. Cu...

Analysis of Covid-19 Situations in Davanagere District, Karnataka

Background: According to CDC, Coronavirus disease 2019 (COVID-19) is caused by a new coronavirus which was first identified in Wuhan, China, in December 2019. Although most people who have COVID-19 have mild symptoms, i...

Lockdown and Your Eyes

All of us are subjected to three months of lockdown period due to Covid 19 pandemic. We are now forced to work from home and our children are attending on line virtual classes.

Download PDF file
  • EP ID EP746485
  • DOI 10.23880/jqhe-16000130
  • Views 19
  • Downloads 0

How To Cite

Turabian JL* (2019). Polypharmacy is an Indicator of Bad Practice and Low Quality in General Medicine. Journal of Quality in Health Care & Economics (JQHE), 2(4), -. https://europub.co.uk/articles/-A-746485